BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33189001)

  • 1. External validation of nodal failure prediction models including radiomics in head and neck cancer.
    Zhai TT; Wesseling F; Langendijk JA; Shi Z; Kalendralis P; van Dijk LV; Hoebers F; Steenbakkers RJHM; Dekker A; Wee L; Sijtsema NM
    Oral Oncol; 2021 Jan; 112():105083. PubMed ID: 33189001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment radiomic features predict individual lymph node failure for head and neck cancer patients.
    Zhai TT; Langendijk JA; van Dijk LV; van der Schaaf A; Sommers L; Vemer-van den Hoek JGM; Bijl HP; Halmos GB; Witjes MJH; Oosting SF; Noordzij W; Sijtsema NM; Steenbakkers RJHM
    Radiother Oncol; 2020 May; 146():58-65. PubMed ID: 32114267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.
    Fatehi KS; Thiagarajan S; Dhar H; Purandare N; DCruz AK; Chaukar D; Laskar SG; Prabhash K; Rangarajan V
    Auris Nasus Larynx; 2019 Aug; 46(4):599-604. PubMed ID: 30594328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States.
    Aggarwal H; Punekar RS; Li L; Carter GC; Walker MS
    Health Qual Life Outcomes; 2020 Jun; 18(1):195. PubMed ID: 32571349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
    Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
    Yuan Y; Ren J; Shi Y; Tao X
    Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral cavity and pharyngo-laryngeal squamous cell carcinoma. What lymph node volumes to select for external beam radiation therapy?].
    Sidibe I; Biau J; Graff P
    Cancer Radiother; 2019 Oct; 23(6-7):696-700. PubMed ID: 31447343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
    Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
    PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
    Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
    Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative US Delta Radiomics to Predict Radiation Response in Individuals with Head and Neck Squamous Cell Carcinoma.
    Osapoetra LO; Dasgupta A; DiCenzo D; Fatima K; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230029. PubMed ID: 38391311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic-assisted selective neck dissection via small lateral neck incision for early-stage (T1-2N0M0) head and neck squamous cell carcinoma: 3-year follow-up results.
    Liang F; Fan S; Han P; Cai Q; Lin P; Chen R; Yu S; Huang X
    Surg Endosc; 2017 Feb; 31(2):894-900. PubMed ID: 27369288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
    de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
    Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
    Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
    Lee YG; Kang EJ; Keam B; Choi JH; Kim JS; Park KU; Lee KE; Kwon JH; Lee KW; Kim MK; Ahn HK; Shin SH; Kim HR; Kim SB; Yun HJ
    BMC Cancer; 2020 Aug; 20(1):813. PubMed ID: 32854649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy.
    Porceddu SV; Pryor DI; Burmeister E; Burmeister BH; Poulsen MG; Foote MC; Panizza B; Coman S; McFarlane D; Coman W
    Head Neck; 2011 Dec; 33(12):1675-82. PubMed ID: 22076976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical lymph node metastasis: assessment of radiologic criteria.
    van den Brekel MW; Stel HV; Castelijns JA; Nauta JJ; van der Waal I; Valk J; Meyer CJ; Snow GB
    Radiology; 1990 Nov; 177(2):379-84. PubMed ID: 2217772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal volume as a prognostic factor in locally advanced head and neck cancer: Identifying candidates for elective neck dissection after chemoradiation with IGRT from a single institutional prospective series from the Indian subcontinent.
    Dua B; Chufal KS; Bhatnagar A; Thakwani A
    Oral Oncol; 2018 Dec; 87():179-185. PubMed ID: 30527237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Maguire PD; Neal CR; Hardy SM; Schreiber AM
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1210-1216. PubMed ID: 29452770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.